These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 1465925)

  • 1. Is superior graft survival of multiorgan donor kidneys due to better preservation or better organ selection?
    Albrecht KH; Rudy T; Niebel W; Eigler FW
    Transplant Proc; 1992 Dec; 24(6):2748-9. PubMed ID: 1465925
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

  • 3. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
    Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
    Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
    Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
    Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
    [No Abstract]   [Full Text] [Related]  

  • 5. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract]   [Full Text] [Related]  

  • 6. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
    Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
    Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
    Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
    Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract]   [Full Text] [Related]  

  • 9. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
    Schanz D; Blümke M; Keller E; Tanzi-Fetta RF; Kirste G
    Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of HLA typing in clinical kidney transplants: 30 years later.
    Matas AJ; Najarian JS
    Clin Transpl; 1993; ():428-30. PubMed ID: 7918175
    [No Abstract]   [Full Text] [Related]  

  • 14. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
    Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
    Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
    [No Abstract]   [Full Text] [Related]  

  • 15. The graft survival curve: ideology and rhetoric.
    Guttmann RD
    Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
    [No Abstract]   [Full Text] [Related]  

  • 16. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 18. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B; Ekberg H; Johnson U
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.